Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hans K. Haugland"'
Autor:
Håvard E. Danielsen, Jone Trovik, Helga B. Salvesen, Knut Liestøl, Fritz Albregtsen, Line Bjørge, Henrica M.J. Werner, Frederic Amant, Margaret S. Lode, Jostein Tjugum, Jan A. Rokne, Klaus Oddenes, Runar Eraker, Hans K. Haugland, Anne C. Staff, Solveig Tingulstad, Janusz Marcickiewicz, Manohar Pradhan, Wanja Kildal, Marna L. Kjæreng, John Arne Nesheim, Rolf Anders Syvertsen, Birgitte Nielsen, Tormund S. Njølstad, Tarjei S. Hveem
Supplementary information describing the Nucleotyping method in more detail, including the training and validation results for the calculated Nucleotyping features.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d7506a7f8319d75d9bff66f55f44cd4
https://doi.org/10.1158/1055-9965.22436458.v1
https://doi.org/10.1158/1055-9965.22436458.v1
Autor:
Håvard E. Danielsen, Jone Trovik, Helga B. Salvesen, Knut Liestøl, Fritz Albregtsen, Line Bjørge, Henrica M.J. Werner, Frederic Amant, Margaret S. Lode, Jostein Tjugum, Jan A. Rokne, Klaus Oddenes, Runar Eraker, Hans K. Haugland, Anne C. Staff, Solveig Tingulstad, Janusz Marcickiewicz, Manohar Pradhan, Wanja Kildal, Marna L. Kjæreng, John Arne Nesheim, Rolf Anders Syvertsen, Birgitte Nielsen, Tormund S. Njølstad, Tarjei S. Hveem
Background: Most endometrial carcinoma patients are diagnosed at an early stage with a good prognosis. However, a relatively low fraction with lethal disease constitutes a substantial number of patients due to the high incidence rate. Preoperative id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39782c2a93a99729dc730112dbb5c0d2
https://doi.org/10.1158/1055-9965.c.6515410
https://doi.org/10.1158/1055-9965.c.6515410
Autor:
Hans K, Haugland, Nina L, Jebsen, Monica, Mannelqvist, Robert, Skar, Johan, Eide, Kjell, Øvrebø, Arild, Horn, Dag K, Jensen, Odd R, Monge, Peer K, Lilleng
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 125(7)
Gastrointestinal stromal tumour (GIST) is the most frequent mesenchymal tumour type of the digestive tract. Between 30 and 40% of patients have high-risk, malignant GIST with poor prognosis after surgery. Imatinib mesylate is a recently introduced KI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0b9c696ae39835d15bbb7f6494cd73c
https://pubmed.ncbi.nlm.nih.gov/15815732
https://pubmed.ncbi.nlm.nih.gov/15815732
